Italia markets open in 7 hours 48 minutes

China Resources Beer (Holdings) Company Limited (0291.HK)

HKSE - HKSE Prezzo differito. Valuta in HKD.
Aggiungi a portafoglio
60,150-0,400 (-0,66%)
Alla chiusura: 04:08PM HKT
Schermo intero
Chiusura precedente60,550
Aperto60,550
Denaro60,150 x 0
Lettera60,200 x 0
Min-Max giorno59,350 - 61,200
Intervallo di 52 settimane53,350 - 76,000
Volume4.676.264
Media Volume7.728.797
Capitalizzazione195,127B
Beta (5 anni mensile)0,71
Rapporto PE (ttm)134,56
EPS (ttm)0,447
Prossima data utili21 mar 2022 - 25 mar 2022
Rendimento e dividendo (forward)0,47 (0,78%)
Data ex dividendo31 ago 2021
Stima target 1A75,99
  • GlobeNewswire

    Zealand Pharma increases its share capital as a consequence of exercise of employee warrants

    Company announcement – No. 74 / 2021 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, DK and Boston, MA, U.S. December 10, 2021 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, has increased its share capital by a nominal amount of DKK 5,400 divided into 5,400 new shares with a nominal value of DKK 1 each. The in

  • GlobeNewswire

    Zealand Pharma major shareholder announcement: The Capital Group Companies, 2021

    Company announcement – No. 73 / 2021 Zealand Pharma major shareholder announcement: The Capital Group Companies, 2021 Copenhagen, DK and Boston, MA, November 30, 2021 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announces the receipt of notification pursuant to Section 38 of the Danish Capital Markets Act from the following major shareholders: T

  • GlobeNewswire

    Total number of shares and voting rights in Zealand Pharma at November 30, 2021

    Company announcement – No. 72 / 2021 Total number of shares and voting rights in Zealand Pharma at November 30, 2021 Copenhagen, DK and Boston, MA, November 30, 2021 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with section 32 of the Danish Capital Markets Act, announces the total number of shares and voting rights in the Company at the